The following table is for layout only Goto Main Navigation | Goto Main Content | Goto Banner | Goto Logon Box | Goto Menu Bar | Goto Search Box | Goto Footer
 

 
Register
|
Return to Listing
Rituximab for autoimmune neutropenia in patient with systemic lupus erythematosus (SLE)
URL/File
 ETA Bromley neutropenia.doc [92.5K]​ - Downloaded 2 times. Last downloaded 27 Jun 2012 16:30.
FormatMS Word Document (.doc)
Home LocationLHO
National or RegionalRegional
start of decorative frame for
start of content for
Publication date22 Feb 2012
Creator(s)NHS Bromley, London and South East Medicines Information
end of content for
end of decorative frame for
start of decorative frame for
start of content for
Is part of
end of content for
end of decorative frame for
start of decorative frame for
start of content for
Rituximab for systemic lupus erythematosus (SLE)
Rituximab for a 32 year old patient with immune thrombocytopenia and neutropenia and at risk of developing life-threatening neutropaenic sepsis
Rituximab monotherapy for heavily pretreated patient with chronic lymphocytic leukaemia
Rituximab for rheumatoid arthritis in patient not suitable for TNF blocker
Tocilizumab for systemic amyloidosis AA type secondary to ankylosing spondylitis
More...
end of content for
end of decorative frame for
start of decorative frame for
start of content for
KeywordsClinical exceptions
Exceptional treatments
IFR
Individual funding requests
Lupus
Neutropenia
Rituximab
end of content for
end of decorative frame for
start of decorative frame for Type and Language
Type and Language
start of content for Type and Language
Resource Typereport
end of content for Type and Language
end of decorative frame for Type and Language